Min Young Lee Selected Research

piperlonguminine

8/2014	In vitro inhibitory effect of piperlonguminine isolated from Piper longum on human cytochrome P450 1A2.
8/2013	Barrier protective effects of piperlonguminine in LPS-induced inflammation in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Min Young Lee Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 10/2011
11	Inflammation (Inflammations) 06/2020 - 04/2009
7	Infections 09/2021 - 09/2013
7	Hearing Loss (Hearing Impairment) 01/2021 - 12/2013
5	Hypoxia (Hypoxemia) 04/2015 - 04/2008
4	Pain (Aches) 01/2021 - 06/2018
4	Fibrosis (Cirrhosis) 01/2020 - 01/2017
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2020
3	Huntington Disease (Huntington's Disease) 12/2021 - 05/2013
3	Sensorineural Hearing Loss 01/2021 - 03/2019
3	Neuromyelitis Optica (Devic's Disease) 01/2021 - 05/2020
3	Ototoxicity 12/2019 - 01/2015
3	Major Depressive Disorder (Major Depressive Disorders) 07/2019 - 01/2016
3	Diabetes Mellitus 09/2018 - 01/2017
3	Hepatocellular Carcinoma (Hepatoma) 11/2017 - 10/2015
3	Carcinoma (Carcinomatosis) 10/2015 - 08/2014
2	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 01/2016
2	Osteoarthritis 01/2021 - 01/2021
2	Respiratory Hypersensitivity 02/2020 - 01/2020
2	Hidden Hearing Loss 01/2020 - 11/2019
2	Tinnitus 08/2019 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2019 - 01/2015
2	Body Weight (Weight, Body) 12/2018 - 01/2009
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2018 - 01/2018
2	Glioma (Gliomas) 08/2018 - 03/2017
2	Wounds and Injuries (Trauma) 06/2018 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 11/2015
2	B-Cell Lymphoma (Lymphoma, B Cell) 11/2017 - 10/2015
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017 - 11/2015
2	Lung Neoplasms (Lung Cancer) 10/2015 - 06/2013
2	Atherosclerosis 10/2015 - 01/2015
2	Breast Neoplasms (Breast Cancer) 10/2011 - 03/2008
2	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2010 - 01/2009
2	Proteinuria 12/2010 - 01/2009
1	Essential Thrombocythemia 04/2022
1	Facial Nerve Injuries 10/2021
1	Papilloma (Papillomatosis) 09/2021
1	Adenocarcinoma 08/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2021
1	Headache (Headaches) 02/2021
1	Meningitis 02/2021
1	Rheumatoid Arthritis 01/2021

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2011
6	Protein Isoforms (Isoforms)IBA 01/2020 - 08/2008
6	Proteins (Proteins, Gene)FDA Link 11/2017 - 10/2011
5	phytobacteriomycin (PBM)IBA 09/2021 - 03/2019
4	Pharmaceutical PreparationsIBA 01/2020 - 09/2011
4	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2019 - 01/2017
4	Streptozocin (Streptozotocin)FDA Link 09/2018 - 01/2016
3	CytokinesIBA 01/2022 - 01/2020
3	AntibodiesIBA 01/2021 - 01/2019
3	LipopolysaccharidesIBA 06/2020 - 04/2009
3	Histones (Histone)IBA 01/2020 - 05/2013
3	AcidsIBA 01/2020 - 01/2009
3	MicroRNAs (MicroRNA)IBA 07/2019 - 03/2017
3	Cytochrome P-450 CYP2J2 (CYP2J2)IBA 11/2017 - 08/2014
2	HeterochromatinIBA 12/2021 - 11/2017
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2021 - 01/2020
2	Analgesics (Analgesic Drugs)IBA 02/2021 - 01/2021
2	SteroidsIBA 02/2021 - 01/2020
2	Iodoacetic AcidIBA 01/2021 - 01/2021
2	Ouabain (G Strophanthin)IBA 01/2021 - 10/2016
2	Glial Fibrillary Acidic ProteinIBA 01/2021 - 01/2020
2	FibrinIBA 01/2021 - 05/2019
2	Kanamycin FDA Link 01/2021 - 01/2015
2	Immunoglobulin E (IgE)IBA 02/2020 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2020 - 04/2019
2	Therapeutic UsesIBA 12/2019 - 09/2018
2	AntioxidantsIBA 04/2019 - 04/2008
2	Cisplatin (Platino)FDA LinkGeneric 03/2018 - 01/2009
2	LipidsIBA 03/2018 - 01/2018
2	Biological ProductsIBA 01/2018 - 08/2014
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2017 - 10/2015
2	Caspase 3 (Caspase-3)IBA 11/2017 - 04/2008
2	Blood Proteins (Serum Proteins)IBA 01/2016 - 10/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2015 - 04/2008
2	cobaltous chloride (cobalt(II)chloride)IBA 04/2015 - 07/2014
2	piperlonguminineIBA 08/2014 - 08/2013
2	Masoprocol (Actinex)FDA Link 01/2009 - 01/2009
2	p38 Mitogen-Activated Protein KinasesIBA 08/2008 - 04/2008
1	IronIBA 04/2022
1	Immune Checkpoint InhibitorsIBA 11/2021
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2021
1	Gemcitabine FDA Link 08/2021
1	RNA (Ribonucleic Acid)IBA 05/2021

Therapy/Procedure

12	Therapeutics 11/2021 - 09/2011
8	Low-Level Light Therapy (LLLT) 10/2021 - 12/2013
6	Drug Therapy (Chemotherapy) 08/2021 - 02/2015
3	Stents 01/2021 - 03/2011
3	Aftercare (After-Treatment) 09/2018 - 04/2015
2	Transplantation 01/2021 - 01/2017
2	Injections 01/2020 - 01/2009
2	Semiconductor Lasers 11/2019 - 12/2013
2	Lasers (Laser) 01/2019 - 12/2013
2	Laser Therapy (Surgery, Laser) 10/2016 - 01/2016
1	Phototherapy (Light Therapy) 09/2021
1	Skin Care 09/2021
1	Epidural Injections 02/2021